Company intelligence / Profile preview

Pharmaceutical Development Consultant

Ownership: Private
Development stage: Phase 1

Overview

Pharmaceutical Development Group (PDG) is an FDA regulatory consulting firm that assists life sciences companies with US submission, approval, and post-marketing procedures. They provide strategic drug development services throughout product lifecycles to maximize safety, efficacy, and commercial value. Their team includes former FDA reviewers and regulatory experts with decades of experience in biologics, quality assurance, CMC (Chemistry Manufacturing Controls), clinical development planning, and compliance.[1]

Modalities: Small moleculesBiologicsCombination products
Industry: Consulting

Drug pipeline

1 asset

nefopam

Phase 1

Indications: Acute pain, Chronic pain

Beyond the preview

Go deeper on Pharmaceutical Development Consultant.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pharmaceutical Development Consultant.

Explore the full profile